a Laboratorio de Modelado Molecular, Bioinformática y Diseño de fármacos, Sección de Estudios de Posgrado e Investigación , Escuela Superior de Medicina, Instituto Politécnico Nacional , Mexico City 11340 , Mexico.
J Biomol Struct Dyn. 2019 Feb;37(3):584-610. doi: 10.1080/07391102.2018.1441072. Epub 2018 Mar 6.
Histone deacetylases (HDACs) are a family of proteins whose main function is the removal of acetyl groups from lysine residues located on histone and non-histone substrates, which regulates gene transcription and other activities in cells. HDAC1 dysfunction has been implicated in cancer development and progression; thus, its inhibition has emerged as a new therapeutic strategy. Two additional metal binding sites (Site 1 and Site 2) in HDACs have been described that are primarily occupied by potassium ions, suggesting a possible structural role that affects HDAC activity. In this work, we explored the structural role of potassium ions in Site 1 and Site 2 and how they affect the interactions of compounds with high affinities for HDAC1 (AC1OCG0B, Chlamydocin, Dacinostat and Quisinostat) and SAHA (a pan-inhibitor) using molecular docking and molecular dynamics (MD) simulations in concert with a Molecular-Mechanics-Generalized-Born-Surface-Area (MMGBSA) approach. Four models were generated: one with a potassium ion (K) in both sites (HDAC1), a second with K only at site 1 (HDAC1), a third with K only at site 2 (HDAC1) and a fourth with no K (HDAC1). We found that the presence or absence of K not only impacted the structural flexibility of HDAC1, but also its molecular recognition, consistent with experimental findings. These results could therefore be useful for further structure-based drug design studies addressing new HDAC1 inhibitors.
组蛋白去乙酰化酶(HDACs)是一类蛋白质,其主要功能是从位于组蛋白和非组蛋白底物上的赖氨酸残基上去除乙酰基,从而调节细胞中的基因转录和其他活动。HDAC1 功能障碍与癌症的发生和发展有关;因此,其抑制作用已成为一种新的治疗策略。已经描述了 HDACs 中的另外两个金属结合位点(Site 1 和 Site 2),主要由钾离子占据,表明其可能具有影响 HDAC 活性的结构作用。在这项工作中,我们通过分子对接和分子动力学(MD)模拟,结合分子力学广义 Born 表面面积(MMGBSA)方法,研究了钾离子在 Site 1 和 Site 2 中的结构作用,以及它们如何影响与 HDAC1 具有高亲和力的化合物(AC1OCG0B、Chlamydocin、Dacinostat 和 Quisinostat)和 SAHA(pan-inhibitor)的相互作用。生成了四个模型:一个在两个位点(HDAC1)都有钾离子(K),一个只有 Site 1 有 K(HDAC1),一个只有 Site 2 有 K(HDAC1),一个没有 K(HDAC1)。我们发现,K 的存在与否不仅影响 HDAC1 的结构灵活性,还影响其分子识别,这与实验结果一致。因此,这些结果可能有助于进一步开展基于结构的药物设计研究,以开发新的 HDAC1 抑制剂。